| miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance M Mutlu, U Raza, Ö Saatci, E Eyüpoğlu, E Yurdusev, Ö Şahin Journal of Molecular Medicine 94, 629-644, 2016 | 139 | 2016 |
| Heterozygous Deep‐Intronic Variants and Deletions in ABCA4 in Persons with Retinal Dystrophies and One Exonic ABCA4 Variant NM Bax, R Sangermano, S Roosing, AAHJ Thiadens, LH Hoefsloot, ... Human mutation 36 (1), 43-47, 2015 | 85 | 2015 |
| miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer M Mutlu, Ö Saatci, SA Ansari, E Yurdusev, H Shehwana, Ö Konu, U Raza, ... Scientific reports 6 (1), 32541, 2016 | 70 | 2016 |
| The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer U Raza, Ö Saatci, S Uhlmann, SA Ansari, E Eyüpoğlu, E Yurdusev, ... Oncotarget 7 (31), 49859, 2016 | 58 | 2016 |
| Functional radiogenetic profiling implicates ERCC6L2 in non-homologous end joining P Francica, M Mutlu, VA Blomen, C Oliveira, Z Nowicka, A Trenner, ... Cell reports 32 (8), 2020 | 36 | 2020 |
| Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents NM Gerhards, VA Blomen, M Mutlu, J Nieuwenhuis, D Howald, ... Molecular oncology 12 (6), 953-971, 2018 | 12 | 2018 |
| MIR200C (microRNA 200c) M Mutlu, Ö Saatçi, U Raza, E Eyüpoglu, E Yurdusev, Ö Sahin Atlas Genet Cytogenet Oncol Haematol 19, 270-285, 2015 | 5 | 2015 |
| Volcano-stratigraphy of the extension-related silicic volcanism of the Çubukludağ Graben, western Turkey: an example of generation of pyroclastic density currents Z Karacik, SC Genc Geological Magazine 151 (3), 492-516, 2014 | 5 | 2014 |
| The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. Oncotarget. 2016; 7 … U Raza, O Saatci, S Uhlmann, SA Ansari, E Eyüpoğlu, E Yurdusev, ... | 5 | |
| MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells A Zelceski, P Francica, L Lingg, M Mutlu, C Stok, M Liptay, J Alexander, ... Cell reports 42 (5), 2023 | 2 | 2023 |
| MDC1 counteracts restrained replication fork restart and its loss causes chemoresistance in BRCA1/2-deficient mammary tumors M Liptay, JS Barbosa, E Gogola, AA Duarte, D Dibitetto, JA Schmid, ... Biorxiv, 2022.08. 18.504391, 2022 | 2 | 2022 |
| A novel HERC4-dependent glue degrader targeting STING M Mutlu, I Schmidt, AI Morrison, B Goretzki, F Freuler, D Begue, ... BioRxiv, 2023.02. 08.527642, 2023 | 1 | 2023 |
| Combinatorial targeting of PI3K and MAPK signaling pathways using microRNAs to inhibit tumor growth and metastasis in breast cancer M Mutlu, O Saatci, E Eyupoglu, U Raza, O Sahin Cancer Research 76 (14_Supplement), 1912-1912, 2016 | 1 | 2016 |
| Erol Eyüpoğlu, Emre Yurdusev & Özgür Şahin M Mutlu, U Raza, Ö Saatci J Mol Med 94, 629-644, 2016 | 1 | 2016 |
| Small molecule induced STING degradation facilitated by the HECT ligase HERC4 M Mutlu, I Schmidt, AI Morrison, B Goretzki, F Freuler, D Begue, O Simic, ... Nature communications 15 (1), 4584, 2024 | | 2024 |
| Structural basis of dual BACH1 regulation by SCFFBXO22 and SCFFBXL17 B Goretzki, M Khoshouei, P Penner, C Stephan, D Argoti, N Dierlamm, ... bioRxiv, 2024.06. 03.596960, 2024 | | 2024 |
| BRCA-deficient mouse mammary tumour organoids as a rapid tool to study anti-cancer drug resistance S Rottenberg, A Duartey, E Duartey, P Francica, M Mutlu, S Blatter, ... Journal of Comparative Pathology 166, 120, 2019 | | 2019 |
| Combinatorial targeting of PI3K and MAPK pathways by miR-564 to inhibit proliferation and invasion in breast cancer M Mutlu PQDT-Global, 2016 | | 2016 |
